Wordt geladen...
2414. Real-World Evaluation of Patient Characteristics and Outcomes of Patients Treated With Ceftolozane/Tazobactam Across 253 US Hospitals
BACKGROUND: Treatment of patients with Gram negative infections is increasingly difficult due to rising resistance to commonly used agents. Ceftolozane/tazobactam (C/T) is a potent anti-pseudomonal agent with broad Gram-negative coverage, that is indicated for cUTI and cIAI and currently being studi...
Bewaard in:
| Gepubliceerd in: | Open Forum Infect Dis |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6253216/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2067 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|